Accelerate to discover
Related topics
Bruker webinar: Ear evolution in fossil mammals
Nov 27, 2020
Hearing is just one of the functions aside of providing balance. Even juveniles obtain a fully developed ear region...
Curiox webinar - how to retain more cells for Single Cell Sequencing and proteogenomics ?
Oct 28, 2020
Do you think that centrifuging cells at 500 x g is not going to cause issues? Moreover, sample prep involving...
Developing tools for multiplex to single EV analysis pipelines
Sep 30, 2020
Extracellular vesicles (EVs) are lipid spheres released from cells. EVs express proteins and contain cargo that pertain...
IncuCyte webinar : clonal heterogeneity promotes metabolite exchange to support pancreatic tumor
Sep 25, 2020
Pancreatic ductaladenocarcinoma (PDA) is the third leading cause of cancer related death in the United States,...
Quantitative evaluation of pulmonary function with hyperpolarized xenon gas MR
Aug 20, 2020
Hyperpolarized 129Xe MR has been proven to be a powerful tool to evaluate the pulmonary function and has been widely...
Applications of Hyperpolarized 129Xe MRI for functional imaging of the lungs
Aug 11, 2020
2015 marked the first ever translation of hyperpolarized gas MRI to diagnostic clinical practice. Research at the...
Micro-CT: Fancy gadget or indispensable technology towards quantification of lung diseases?
Jul 29, 2020
Technology allowing evaluation of live animals repeatedly is indispensable to gain better insight into the dynamics of...
Breakthrough discoveries from shear flow assays for Platelet biology and vascular studies
Jul 17, 2020
After a short introduction on the physio-pathological roles of platelets and the importance of their cell adhesion...
Jun 13, 2016
Friday, June 17th, 2016, 5 pm CEST.
High content functional assays that can monitor parameters such as membrane integrity, cytokine release, and more, are critical to understanding target cell response to immunotherapies and allow for rational design of improved therapies.
This webinar will highlight:
- Challenges posed by current methods to screen the efficacy of immunotherapies.
- The need for high content robust tools to evaluate current immunotherapeutic approaches such as adoptive cell therapy, checkpoint blockade etc.
- The ability of the iQue Screener platform to acquire single-cell data on multiple biological readouts in a quantitative, high-throughput fashion and better understand functional efficacy of immuno-oncology therapies.
Get more info
Brand profile
IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
More info at:
www.intellicyt.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
